Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of a New Leuprolide Acetate 22.5 mg Depot Formulation in the Treatment of Prostate Cancer

NCT01415960 is registered in ClinicalTrials.gov with GP-Pharm as lead sponsor.

NCT NCT01415960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01415960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of a New Leuprolide Acetate 22.5 mg Depot Formulation in the Treatment of Prostate Cancer
Lead sponsor
GP-Pharm
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2011
Completion date
November 30, 2013
Enrollment
163 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer